0.5292
price up icon17.26%   0.0791
 
loading

Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten

pulisher
08:44 AM

Iterum Therapeutics expands reimbursement coverage for ORLYNVAH - Investing.com

08:44 AM
pulisher
08:07 AM

Iterum Therapeutics provides business update - marketscreener.com

08:07 AM
pulisher
08:03 AM

Iterum Therapeutics Provides Business Update - The Manila Times

08:03 AM
pulisher
08:00 AM

Iterum Therapeutics (Nasdaq: ITRM) inks Medicare Part D deal, EU patent to 2039 - Stock Titan

08:00 AM
pulisher
Dec 02, 2025

Taking on analysts’ expectations and winning: Iterum Therapeutics Plc (ITRM) - Setenews

Dec 02, 2025
pulisher
Dec 02, 2025

Iterum Therapeutics (ITRM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025
pulisher
Nov 25, 2025

Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews

Nov 25, 2025
pulisher
Nov 24, 2025

Iterum’s antibiotic ORLYNVAH now available through McKesson By Investing.com - Investing.com Nigeria

Nov 24, 2025
pulisher
Nov 24, 2025

Iterum’s antibiotic ORLYNVAH now available through McKesson - Investing.com

Nov 24, 2025
pulisher
Nov 24, 2025

Iterum Therapeutics (ITRM) Expands Product Availability and FDA Clearance - GuruFocus

Nov 24, 2025
pulisher
Nov 24, 2025

Iterum (NASDAQ: ITRM) Adds McKesson for ORLYNVAH as Sulopenem Disc Gains FDA 510(k) - Stock Titan

Nov 24, 2025
pulisher
Nov 22, 2025

Q3 2025 Iterum Therapeutics PLC Earnings Call Transcript - GuruFocus

Nov 22, 2025
pulisher
Nov 21, 2025

Is Iterum Therapeutics plc stock attractive after correctionPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why retail investors favor Iterum Therapeutics plc stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Can Iterum Therapeutics plc stock maintain operating marginsJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Iterum Therapeutics director Dunne buys $2,191 in shares By Investing.com - Investing.com Nigeria

Nov 20, 2025
pulisher
Nov 20, 2025

Dir Dunne Buys 6,000 ($2.2K) Of Iterum Therapeutics PLC [ITRM] - TradingView

Nov 20, 2025
pulisher
Nov 20, 2025

[Form 4] Iterum Therapeutics plc Insider Trading Activity - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

Can Iterum Therapeutics plc stock resist market sell offs2025 Big Picture & Fast Gain Swing Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why Iterum Therapeutics plc stock appeals to analysts2025 Technical Overview & High Accuracy Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Combining machine learning predictions for Iterum Therapeutics plc2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 01:58:59 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Iterum Therapeutics plc stock attractive for long term wealth buildingQuarterly Market Review & Risk Managed Investment Strategies - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Using portfolio simulators with Iterum Therapeutics plc includedMarket Trend Report & Reliable Entry Point Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

There is no way Iterum Therapeutics Plc (ITRM) can keep these numbers up - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

Visualizing Iterum Therapeutics plc stock with heatmaps2025 Year in Review & Expert Verified Movement Alerts - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

Will Iterum Therapeutics plc stock split attract more investorsCPI Data & Reliable Breakout Forecasts - newser.com

Nov 16, 2025
$39.17
price down icon 0.09%
$31.77
price down icon 0.81%
$100.96
price up icon 0.44%
$96.19
price up icon 0.29%
biotechnology ONC
$316.03
price down icon 4.63%
$204.48
price down icon 0.16%
Kapitalisierung:     |  Volumen (24h):